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InjuryTherapy with hyperoxia is often needed to treat newborns
with respiratory disorders. Supplemental oxygen adminis-
tered to newborn infants with respiratory failure can in-
crease oxidant stress and lead to lung injury. Lung injury
often resolves with fibrosis, which is prominent in larger in-
fants after prolonged exposure to oxygen and mechanical
ventilation.1 Prolonged exposure of neonatal rats to hyper-
oxia resulted in decreased alveolar septation, increased
terminal air space size, and increased lung fibrosis, which is
very similar to human bronchopulmonary dysplasia (BPD).2 It
is originally manifested with mucosal metaplasia of the air-
ways, emphysema, and widespread interstitial fibrosis.
Improved medical care, including antenatal steroids, post-
natal surfactant therapy, and better ventilator strategies
and nutritional support, has allowed survival of the most
premature infants and has significantly altered the pathol-
ogy of BPD from severe lung injury to the new BPD. The new
BPD is characterized by impaired alveolar formation and
vascular development.3 Despite the recent improvements in
preventing respiratory distress syndrome in preterm infants,
BPD remains amajor cause of morbidity andmortality during
the first year of life and many infants have significant res-
piratory problems throughout childhood, including
increased airway reactivity and development of obstructive
airway disease throughout childhood.4 More than 30% of
preterm infants born before the gestational age of 30 weeks
develop BPD. Currently no effective therapy is clinically
available to prevent long-term pulmonary sequelae of BPD.
Thus, it is important to explore new strategies for the pre-
vention and treatment of BPD.
In this issue of Pediatrics and Neonatology, Ozdemir et al5
used resveratrol, a natural phytoalexin present in grapes,
peanuts, and mulberries, to treat hyperoxia-induced lung
injury in newborn rats. Resveratrol has antioxidant and anti-
inflammatory activities and has been shown to reduce lung
injury in sepsis and bleomycin-induced lung injury. They
found that resveratrol significantly reduced the fibrosis score,
nitric oxide and tumor necrosis factor-a levels, and increased
the glutathione and superoxide dismutase levels in the
hyperoxia group.http://dx.doi.org/10.1016/j.pedneo.2014.04.002
1875-9572/Copyright ª 2014, Taiwan Pediatric Association. Published bSupraphysiological concentrations of oxygen generate
excessive amounts of reactive oxygen species, which can
activate signaling pathways to induce downstream tar-
gets. The signaling pathway seems to play an important
role in hyperoxic cell death. Extracellular signal-regulated
kinase 1/2, a mitogen-activated protein kinase subfamily
member, plays a crucial role in hyperoxia-induced lung
injury.6 Once oxidative stress damages lung cells, the
injured and dead cells are replaced through an increased
proliferation and differentiation of fibroblasts. Excessive
cell growth and proliferation, collagen overproduction,
and pulmonary fibrosis may result if these courses are not
modified. Ozdemir et al’s5 study showed that oxidative
stress and nitric oxide contributed to the pathogenesis of
hyperoxia-induced lung injury and that resveratrol pre-
vents hyperoxic lung injury. The pathogenesis of BPD is
multifactorial, and researchers consider that pulmonary
oxygen toxicity plays a central role in the lung injury
process. These findings further confirm that pulmonary
inflammation and oxygen toxicity play crucial roles in the
lung injury process, which leads to the development of
BPD.7
The alveolar stage of lung development in the rodent
begins on postnatal Day 4, and saccular division is
completed by postnatal Day 14. The newborn rat is
particularly appropriate for studies of neonatal oxygen
injury because the developmental stage of the rodent lung
at birth overlaps with that of the human preterm neonate
at 24e28 weeks’ gestation. The limitations of animal
models of hyperoxic lung injury are the oxygen concentra-
tions used that exceed the level of oxygen supplementation
currently applied to the preterm infants and the lack of the
fluctuations in oxygen concentrations that are clinically
used in preterm infants. However, animal models are
essential for the study of novel strategies to prevent and
treat hyperoxic lung injury. Future studies are need to
further refine and modify the current animal models to
better mimic the human condition. BPD in very preterm
human neonates involves prenatal insults, e.g., intrauter-
ine growth restriction and infections. Therefore, they Elsevier Taiwan LLC. All rights reserved.
330 Editorialcreation of a perinatal double-hit animal model of BPD
could be critical to mimic closely the pathogenesis in
human preterm neonates as a basis for research on recov-
ery of normal lung growth.
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